This message contains images. If you don't see images, click here to view.
Click here to advertise in this news brief.

  Mobile version   RSS   Subscribe   Unsubscribe   Archive   Media Kit Jan. 4, 2012

Home   About The ATA   Join   Fellows' Corner


American Thyroid Association: Better communication among care team critical for optimal care, surveillance
Endocrine Today    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Physicians who treat patients with thyroid cancer as part of a multidisciplinary treatment team need specific perioperative information, including results from clinical examination, biochemical testing, and cross-sectional and functional imaging tests, among other sources. More

Update from Genzyme on Thyrogen supply
American Thyroid Association    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Genzyme is reporting in a statement that the global supply of Thyrogen will remain limited but improve for 2012. Genzyme anticipates meeting levels that approach 60-80 percent of that delivered in 2010 for the upcoming year. U.S. supplies will likely be towards the upper end of this range. Genzyme recommends that physicians seek to obtain Thyrogen for their patient through their usual suppliers but wait until it is secured before scheduling Thyrogen use in their patients. More

Hyperparathyroidism charting in EMR can be easy

With the right tools and workflow, charting an initial consultation for Hyperparathyroidism can be very easy and quick. You can also setup and manage reminders for yearly calcium levels automatically. Click here to see the video.

Only a few pediatric patients with subclinical hypothyroidism to progress to overt disease within 3 years
Clinical Thyroidology    Share    Share on FacebookTwitterShare on LinkedinE-mail article
To treat or not to treat, that is the question. Should a pediatric patient with an isolated increase of serum thyrotropin (TSH) or with positive thyroid autoantibodies but with normal free thyroxine (T4) and free triiodothyronine (T3) levels be treated? Most endocrinologists agree that patients with a serum TSH above 10 mU/L would benefit from thyroxine treatment. In fact, in this situation, serum thyroid hormone levels are mostly at the lower limit of normal or are decreased. More

Radiation protection after a nuclear accident
Clinical Thyroidology for Patients    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Radioactive iodine, specifically I-131, is the major radiation product released from a nuclear accident. The most recent accident was the nuclear reactor damage from the Tsunami in Japan. When radioactive iodine is released into the atmosphere, it can then be absorbed into the body. Eating contaminated foods is another way for by radioactive iodine to get into the body. More

TSI Reporter BioAssay

•Graves’ disease is the primary cause of hyperthyroidism.

•Graves’ disease is characterized by the presence of thyroid stimulating immunoglobulin (TSI).

•Thyretain TSI Reporter BioAssay is the only commercially available IVD for the detection of TSI, the causative agent of Graves’ disease.


Molecular analysis for mutations in thyroid FNA improves the diagnosis of malignancy for all categories of indeterminate cytology
Clinical Thyroidology    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Nodules classified as indeterminate make up about one-fourth of those tested by thyroid fineneedle aspiration biopsy (FNAB). In the Bethesda classification, these are further classified into one of three categories that have increasing likelihood of thyroid cancer: (1) follicular lesion of undetermined significance (FLUS), (2) follicular or oncocytic (Hürthle)-cell neoplasm or suspicious for follicular or oncocytic-cell neoplasm (FN), and (3) suspicious for malignant cells (SMC). More

ATA Thyroid Weekly News Briefs
ATA does not develop, exert any editorial or other control, or guarantee the accuracy, completeness, efficacy, or timeliness, of the materials, information, advertising or promotional activities ("Content") in this publication. Inclusion of Content in this publication does not constitute or imply endorsement, agreement, recommendation, or favoring by ATA of such information or the entities mentioned or promoted herein. Use of any Content appearing or referenced in this publication or obtained from advertisers is voluntary, and reliance on it should only be undertaken after an independent review by qualified experts. ATA is not responsible for, and expressly disclaims all liability for, damages of any kind arising out of use of, reference to, reliance on, or performance pursuant to such Content.

Colby Horton, Vice President of Publishing, 469.420.2601
Download media kit

Julie Bernhard, Sr. Content Editor, 469.420.2647   
Contribute news

This edition of the ATA Thyroid Weekly News Briefs was sent to ##Email##. To unsubscribe, click here. Did someone forward this edition to you? Subscribe here -- it's free!
Recent issues
Jan. 4, 2012
Dec. 28, 2011
Dec. 21, 2011
Dec. 14, 2011

7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063